Connect with us


Cannabis rescheduling will let DC legalize sales (Newsletter: July 3, 2024)



Supreme Court on marijuana & guns; Controversy: Cannabis regulators group & Big Tobacco; ND legalization; German social clubs

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Get our daily newsletter.

Your support makes Marijuana Moment possible…

Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on.

Check us out on Patreon and sign up to give $25/month today:


A new Congressional Research Service report says federal marijuana rescheduling would finally allow Washington, D.C. officials to locally legalize recreational cannabis sales—but there’s a catch, depending on the definition of a “tetrahydrocannabinols derivative.”

The U.S. Supreme Court is remanding a case on marijuana and gun rights back to a lower court in light of a recent ruling in a separate Second Amendment case—and the Department of Justice is doubling down on its position that letting cannabis consumers be armed presents a “heightened risk of harm.”

The Cannabis Regulators Association is under fire from some activists who are accusing the group of breaking its own rules by hosting a representative of a tobacco and alcohol industry-backed organization at a recent meeting. The group disputes that, however.

North Dakota activists say they have collected more than enough signatures to put a marijuana legalization initiative on the November ballot and will formally submit the petitions to state officials next week.

As of this week, German cannabis clubs can officially begin applying to launch operations in accordance with local rules—the latest step in the rollout of the country’s marijuana legalization law.

The Kentucky Office of Medical Cannabis is now accepting applications for marijuana business licenses, and doctors and nurses can begin applying to issue recommendations to patients.


Sen. Chris Murphy (D-CT) said he supports marijuana banking legislation but isn’t sure how he feels about pardons for cannabis offenses.

Rep. Jack Bergman (R-MI) slammed a Food and Drug Administration panel’s rejection of MDMA-assisted therapy in a House floor speech.


The Washington, D.C. Council passed emergency legislation to ramp up enforcement against unlicensed marijuana businesses.

Wyoming officials are being sued over a law restricting intoxicating hemp products.

California regulators are proposing to modify cannabis appellations rules.

Nevada regulators filed proposed changes to marijuana packaging and labeling rules.

Illinois regulators are advancing rulemaking on cannabis infuser business licenses.

Connecticut regulators posted guidance on marijuana business social equity plan requirements.

Delaware regulators sent a warning about “predatory practices” related to marijuana social equity licenses.

Vermont regulators sent a warning about scams targeting cannabis businesses.

A Minnesota law allowing doctors to recommend medical cannabis for any condition they see fit took effect.

A new Maryland law creating a Task Force on Responsible Use of Natural Psychedelic Substances took effect.

Marijuana Moment is tracking more than 1,500 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.


Denver, Colorado officials posted a recap of the latest Natural Medicine Work Group meeting.


The Irish Oireachtas Committee on Drugs Use will hold a hearing on drug legalization and decriminalization on Thursday.


A study’s results “emphasize the potential of CBD for the management of acne because of its anti-inflammatory, apoptotic, and lipid-inhibitory effects.”


Elon Musk said Rep. Dan Crenshaw (R-TX) is “right” about his criticism of a Food and Drug Administration advisory panel’s rejection of MDMA-assisted therapy.


Schwazze is transitioning to the OTC Expert Market.

MariMed Inc. acquired the operating assets of Our Community Wellness & Compassionate Care Center, Inc. in Prince George’s County, Maryland.

Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.

Get our daily newsletter.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Become a patron at Patreon!

Tom Angell is the editor of Marijuana Moment. A 20-year veteran in the cannabis law reform movement, he covers the policy and politics of marijuana. Separately, he founded the nonprofit Marijuana Majority. Previously he reported for and MassRoots, and handled media relations and campaigns for Law Enforcement Against Prohibition and Students for Sensible Drug Policy.


Marijuana News In Your Inbox

Get our daily newsletter.

Support Marijuana Moment

Marijuana News In Your Inbox


Get our daily newsletter.